Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovaBay Pharmaceuticals

0.5800
+0.00981.72%
Post-market: 0.58000.00000.00%19:34 EDT
Volume:12.28K
Turnover:7.12K
Market Cap:3.37M
PE:-0.23
High:0.5872
Open:0.5702
Low:0.5702
Close:0.5702
Loading ...
Jul 29, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 25, 2019

Major Issues Report

Current report, item 5.02
Jul 15, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Jul 01, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 26, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Jun 19, 2019

Major Issues Report

Current report, items 1.01, 3.02, and 9.01
Jun 17, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Major Issues Report

Current report, item 5.07
May 21, 2019

Major Issues Report

Current report, items 3.01 and 9.01
May 15, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 13, 2019

Major Issues Report

Current report, items 2.02 and 9.01
May 03, 2019

Major Issues Report

Current report, item 5.02
Apr 16, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Apr 16, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Apr 12, 2019

[Rev.]Annual Report

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]